Immunological and cytogenetic characterization of lymphocitic mouse leukemias after treatment with antineoplastic drugs.
D000372:Agglutination Tests; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002875:Chromosomes / Q000187:drug effects*; D003208:Concanavalin A / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003606:Dacarbazine / Q000494:pharmacology; D005260:Female; D007942:Leukemia, Experimental / Q000235:genetics / Q000276:immunology*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D010835:Phytohemagglutinins / Q000494:pharmacology
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D010835:Phytohemagglutinins; D003208:Concanavalin A; D003606:Dacarbazine; D003520:Cyclophosphamide